Info on Directors that have recently been appointed to the company board.
N. Scott Fine
Director
Mr. Fine is a principal at Scarsdale Equities; an investment-banking firm located in New York City, and has been involved in corporate finance for over 35 years. Mr. Fine has focused his efforts and has worked or initiated several transactions in the healthcare and consumer products area, including the following:
In healthcare Mr. Fine had advised Research Medical, a specialty medical device manufacturer, on a strategic equity alliance with The Tempo Group of Jakarta, Indonesia. Research Medical was subsequently bought by Baxter. He was the lead investment banker on the Initial Public Offering for Med-Design Corporation, a specialty medical device company, which was thereafter acquired by Specialized Health Products International, Inc. Mr. Fine was the lead investment banker for DermaSciences, Inc., and he advised on several funding transactions for Interleukin Genetics (AMEX ILI), leading to the consummation of an Equity Strategic Alliance with Alticor.
Mr. Fine became a special internal advisor to The Tempo Group of Jakarta, Indonesia, one of Indonesia's largest private groups, whose business focus is in healthcare and consumer products. While working for Tempo, Mr. Fine and his family resided in Jakarta for a period of two years.
He also advised and was the lead banker on the Initial Public Offering of Green Mountain Coffee Roasters (NASDAO GMCR).
Mr. Fine is currently Vice-Chairman of the Board of Central European Distribution.
Markus W. Sieger
Director
Mr. Sieger holds a degree in Economics from the University of Applied Sciences for Business and Administration in Zurich, Switzerland. He started his career in 1981 with Zurich Insurance Group where he specialized in the field of information systems (IS) leading several organizational and IS projects.
In 1994 he joined Fincoord, a company advising entrepreneurs on a 360° approach in emerging markets both on strategic and financial issues. In 1995 he was nominated Managing Partner and became the second largest shareholder. He was actively involved in negotiating and structuring international joint-ventures, coordinating entrepreneurial, financial, fiscal and legal issues. Furthermore he successfully took on and managed on an ad interim basis, high-level operational assignments in the media industry in Poland. During his 19 years at Fincoord he focused on the media, pharmaceutical, engineering and food industries. He holds and has held several supervisory and board of director seats on private and public US and European companies.
In 2007 he initiated and built-up Iscoord, Ltd., an award winning IT consulting and software development company, which he continues to build. Since July 1st, 2013 Markus is independently advising companies active in the media and pharmaceutical industries in the Central and Eastern European region. He speaks German, English and French.
F. Patrick Ostronic
Director
Mr. Ostronic is an officer of US Pharmacia International, Inc., a subsidiary of USP, and also serves as the Chief Financial Officer of The USP Group. Mr. Ostronic is also a director of Novit US, Inc., the general partner of Novit.
